Search Results - "Patel, Sheylan"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways by Patel, Sheylan D, Bono, Taylor R, Rowe, Steven M, Solomon, George M

    Published in European respiratory review (30-06-2020)
    “…Cystic fibrosis transmembrane conductance regulator (CFTR) is an ion transporter that regulates mucus hydration, viscosity and acidity of the airway epithelial…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Laryngeal Actinomycosis in an Immunocompromised Patient by Patel, Sheylan, Jaworek, Aaron J, Patel, Vatsal, Duckworth, Lizette Vila, Sawhney, Raja, Chheda, Neil N

    Published in Journal of voice (01-11-2014)
    “…Summary Actinomycosis of the larynx represents an unusual presentation for a common bacterium comprising the oral and oropharyngeal florae. There are few cases…”
    Get full text
    Journal Article
  4. 4

    Abstract 5622: Development of an experimental model to test cellular therapy in combination with cytokines as a novel treatment for ovarian cancer by Ingersoll, Susan Blaydes, Ahmad, Sarfraz, Patel, Sheylan, Ahmed, Ahad, Edwards, John R., Finkler, Neil J., Holloway, Robert W.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract Because current therapies for ovarian cancer have little impact on long-term survival, there is a compelling need to develop innovative treatment…”
    Get full text
    Journal Article
  5. 5

    Synergistic cytotoxicity of interferonα-2b and interleukin-2 in combination with PBMC against ovarian cancer: Development of an experimental model for cellular therapy by Ingersoll, Susan B, Patel, Sheylan, Caballero, Lizette, Ahmad, Sarfraz, Edwards, Dawn, Holloway, Robert W, Edwards, John R

    Published in Gynecologic oncology (01-01-2009)
    “…Abstract Objectives Current therapies for ovarian cancer (OC) patients have a modest impact on long-term survival justifying the need for novel treatment…”
    Get full text
    Journal Article
  6. 6

    Functional characterization of a fluorescent highly tumorigenic ovarian cancer line to test cellular therapy in experimental models by Ingersoll, Susan Blaydes, Ahmad, Sarfraz, Stoltzfus, Gregory P, Patel, Sheylan, Radi, Michael J, Finkler, Neil J, Edwards, John R, Holloway, Robert W

    “…The objective of this study was to functionally characterize a fluorescent highly tumorigenic ovarian cancer line to test cellular therapy in combination with…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Synergistic cytotoxicity of interferonalpha-2b and interleukin-2 in combination with PBMC against ovarian cancer: development of an experimental model for cellular therapy by Ingersoll, Susan B, Patel, Sheylan, Caballero, Lizette, Ahmad, Sarfraz, Edwards, Dawn, Holloway, Robert W, Edwards, John R

    Published in Gynecologic oncology (01-01-2009)
    “…Current therapies for ovarian cancer (OC) patients have a modest impact on long-term survival justifying the need for novel treatment strategies. We developed…”
    Get full text
    Journal Article